The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices
Open accessAbstract
Introduction: Globally, transgender (“trans”) women are one of the key populations most disproportionately impacted by HIV. Pre‐exposure prophylaxis (PrEP) is the newest and most promising biomedical HIV prevention intervention to date. This paper reviews relevant literature to describe the current state of the science and describes the potential role of PrEP among trans women, including a discussion of unique considerations for maximizing the impact of PrEP for this vulnerable population. Methods: Available information, including but not limited to existing scientific literature, about trans women and PrEP was reviewed and critiqued based on author expertise, including PrEP clinical trials and rollout. Results: To date, PrEP demonstration projects and clinical trials have largely excluded trans women, or have not included them in a meaningful way. Data collection strategies that fail to identify trans women in clinical trials and research further limit the ability to draw conclusions about trans women's unique needs and devise strategies to meet them. Gender‐affirming providers and clinic environments are essential components of any sexual health programme that aims to serve trans women, as they will largely avoid settings that may result in stigmatizing encounters and threats to their identities. While there is currently no evidence to suggest drug‐drug interactions between PrEP and commonly used feminizing hormone regimens, community concerns about potential interactions may limit interest in and uptake of PrEP among trans women. Conclusions: In scaling up PrEP for trans women, it is essential to engage trans communities, utilize trans‐inclusive research and marketing strategies and identify and/or train healthcare providers to provide gender‐affirming healthcare to trans women, including transition‐related care such as hormone provision. PrEP implementation guidelines must consider and address trans women's unique barriers and facilitators to uptake and adherence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationWhite Hughto, J. M., Reisner, S. L., & Pachankis, J. E. (2015) · Social Science & Medicine · doi:10.1016/j.socscimed.2015.11.010 · Cited by 1,680
Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.
Baral, S. D., Poteat, T., Strömdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70315-8 · Cited by 1,461
for the HIV/AIDS Prevention Research Synthesis Team, Herbst, J. H., Jacobs, E. D., Finlayson, T. J., McKleroy, V. S., Neumann, M. S., & Crepaz, N. (2008) · AIDS and Behavior · doi:10.1007/s10461-007-9299-3 · Cited by 933 · cited 1×
“In addition, there is a clear need for increased HIV testing among trans women [18], with some preliminary evidence for feasibility and acceptability of self-testing [19].”
BackgroundLiu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602 · cited 3×
“However, very few if any trans women have actually been enrolled in these trials [28].”
BackgroundGender affirmation: a framework for conceptualizing risk behavior among transgender women of color.
Sevelius, J. M. (2013) · Sex Roles · doi:10.1007/s11199-012-0216-5 · Cited by 572 · cited 2×
“Access to gender-affirming hormones also represents a potential intervention within several constructs of the Model of Gender Affirmation, including reducing barriers to healthcare, reduced body shame, increased access to gender affirmation and reduced use of street hormones or silicone [14].”
BackgroundSevelius, J. M., Patouhas, E., Keatley, J. G., & Johnson, M. O. (2014) · Annals of Behavioral Medicine · doi:10.1007/s12160-013-9565-8 · Cited by 345
Cahill, S., Singal, R., Grasso, C., King, D., Mayer, K., Baker, K., & Makadon, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107104 · Cited by 288
Sevelius, J. (2009) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/j.jana.2009.06.001 · Cited by 150
Self-citation
Cited by
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8
Coleman, E., Radix, A. E., Bouman, W. P., Brown, G. R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., et al. (2022) · International Journal of Transgender Health · doi:10.1080/26895269.2022.2100644 · Cited by 2,698
Self-citationBarriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review
Mayer, K. H., Agwu, A., & Malebranche, D. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01295-0 · Cited by 426
Stutterheim, S. E., van Dijk, M., Wang, H., & Jonas, K. J. (2021) · PLOS ONE · doi:10.1371/journal.pone.0260063 · Cited by 257
Metadata
- Authors
- Sevelius, J. M., Deutsch, M. B., & Grant, R.
- Venue
- Journal of the International AIDS Society
- Publisher
- Wiley
- Published
- 2016-10
- Volume
- 19
- Issue
- 7S6
- Pages
- 21105-21105
- ISSN
- 1758-2652 (ISSN-L)
- OpenAlex
- W2532737935
- Cited by
- 159
- References
- 9
- FWCI
- 10.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. https://app.cochat.ai/papers/10.7448/ias.19.7.21105
- The paper
- Sevelius, J. M., Deutsch, M. B., & Grant, R. (2016). The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices. Journal of the International AIDS Society. https://doi.org/10.7448/ias.19.7.21105
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.